Assembly Biosciences Income Taxes 2010-2024 | ASMB

Assembly Biosciences income taxes from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Assembly Biosciences Annual Income Taxes
(Millions of US $)
2023 $0
2022 $
2021 $-3
2020 $
2019 $-1
2018 $1
2017 $-9
2016 $-1
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Assembly Biosciences Quarterly Income Taxes
(Millions of US $)
2024-06-30 $0
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31 $-1
2019-09-30 $-0
2019-06-30 $-0
2019-03-31 $-0
2018-12-31 $1
2018-09-30 $-0
2018-06-30 $-0
2018-03-31
2017-12-31 $-9
2017-09-30 $-0
2017-06-30 $-0
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31 $0
2010-09-30
2010-06-30
2010-03-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.117B $0.007B
Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.120B 6.83
Dr Reddy's Laboratories (RDY) India $13.079B 19.59
BridgeBio Pharma (BBIO) United States $5.045B 0.00
Bausch Health Cos (BHC) Canada $2.956B 2.23
Amphastar Pharmaceuticals (AMPH) United States $2.438B 13.65
Supernus Pharmaceuticals (SUPN) United States $1.771B 357.00
Taysha Gene Therapies (TSHA) United States $0.449B 73.00
Personalis (PSNL) United States $0.315B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00